To investigate the functional implication of HOXD-AS2 in GBM cells, we applied siRNA targeting HOXD-AS2 in 2 GBM cell lines with high expression of HOXD-AS2 (U87 and LN299). The gene discussed is HOXD-AS2; the disease is glioblastoma.